Assessing the Efficacy of Mitoxantrone and Doxorubicin as Frontline Anthracyclines During Induction Therapy of Newly Diagnosed Acute Promyelocytic Leukemia

Background: Therapeutic advances in acute promyelocytic leukemia (APL) have transformed it into today's most curable form of leukemia. However, recommended agents, including arsenic trioxide, idarubicin, or daunorubicin, are not easily available in low-middle-income countries, where outcomes remain...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	José C. Jaime-Pérez, Eugenia M. Ramos-Dávila, Jesús D. Meléndez-Flores, Mariana González-Treviño, David Gómez-Almaguer
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wolters Kluwer Medknow Publications 2024-01-01
Schriftenreihe:	Hematology/Oncology and Stem Cell Therapy
Schlagworte:	acute promyelocytic leukemia remission induction atra mitoxantrone doxorubicin
Online-Zugang:	https://journals.lww.com/10.56875/2589-0646.1090
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!